Synthesis and calpain inhibitory activity of peptidomimetic compounds with constrained amino acids at the P2 position

Peptidomimetic with P2 α-aminocyclopentane carboxylic acid. μ-Calpain inhibition, Ki=1.94μM, cathepsin B inhibition, Ki=0.88μM. Peptidomimetic with P2 α,α′-diethylglycine. μ-Calpain inhibition, Ki=0.08μM, cathepsin B inhibition, Ki=2.91μM. The effect of incorporating α,α′-diethylglycine and α-aminoc...

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry letters Vol. 18; no. 17; pp. 4806 - 4808
Main Authors Donkor, Isaac O., Korukonda, Rajani
Format Journal Article
LanguageEnglish
Published Oxford Elsevier Ltd 01.09.2008
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Peptidomimetic with P2 α-aminocyclopentane carboxylic acid. μ-Calpain inhibition, Ki=1.94μM, cathepsin B inhibition, Ki=0.88μM. Peptidomimetic with P2 α,α′-diethylglycine. μ-Calpain inhibition, Ki=0.08μM, cathepsin B inhibition, Ki=2.91μM. The effect of incorporating α,α′-diethylglycine and α-aminocyclopentane carboxylic acid at the P2 position of inhibitors on μ-calpain inhibition was studied. Compound 3 with α,α′-diethylglycine was over 20-fold more potent than 2 with α-aminocyclopentane carboxylic acid. Additionally, 3 was over 35-fold selective for μ-calpain compared to cathepsin B, while 2 was 3-fold selective for cathepsin B compared to μ-calpain. Thus, the conformation induced by the P2 residue influenced the activities of the compounds versus the closely related cysteine proteases, and suggests an approach to the discovery of selective μ-calpain inhibitors.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2008.07.094